These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26149603)

  • 1. Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice.
    Wei T; Zhao L; Jia J; Xia H; Du Y; Lin Q; Lin X; Ye X; Yan Z; Gao H
    Sci Rep; 2015 Jul; 5():11998. PubMed ID: 26149603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.
    Li M; Wang X; Aa J; Qin W; Zha W; Ge Y; Liu L; Zheng T; Cao B; Shi J; Zhao C; Wang X; Yu X; Wang G; Liu Z
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1317-24. PubMed ID: 23467425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy.
    Liu J; Wang D; Chen Y; Sun H; He S; Wang C; Yang G; Shi M; Zhang J; Ren Y; Wang L; Lu Y; Cheng J
    Mol Biosyst; 2013 Nov; 9(11):2645-52. PubMed ID: 24228270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ¹H-NMR-based metabonomic analysis of metabolic profiling in diabetic nephropathy rats induced by streptozotocin.
    Zhao L; Gao H; Lian F; Liu X; Zhao Y; Lin D
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F947-56. PubMed ID: 21228107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of urinary metabolite profile in model diabetic nephropathy.
    Stec DF; Wang S; Stothers C; Avance J; Denson D; Harris R; Voziyan P
    Biochem Biophys Res Commun; 2015 Jan; 456(2):610-4. PubMed ID: 25499815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model.
    Kim NH; Hyeon JS; Kim NH; Cho A; Lee G; Jang SY; Kim MK; Lee EY; Chung CH; Ha H; Hwang GS
    Arch Biochem Biophys; 2018 May; 646():90-97. PubMed ID: 29621522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy.
    Liu J; Wang C; Liu F; Lu Y; Cheng J
    Anal Bioanal Chem; 2015 Mar; 407(9):2569-79. PubMed ID: 25636229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathy.
    Zhao L; Gao H; Zhao Y; Lin D
    J Ethnopharmacol; 2012 Aug; 142(3):647-56. PubMed ID: 22687255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.
    Roointan A; Gheisari Y; Hudkins KL; Gholaminejad A
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2253-2272. PubMed ID: 34059383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy.
    Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X
    J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Oxidative Damage of RNA in Early-Stage Nephropathy in db/db Mice.
    Wang WX; Luo SB; Jiang P; Xia MM; Hei AL; Mao YH; Li CB; Hu GX; Cai JP
    Oxid Med Cell Longev; 2017; 2017():2353729. PubMed ID: 29201270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
    Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
    Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urine acylcarnitines in diabetic ApoE-/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia.
    Mirzoyan K; Klavins K; Koal T; Gillet M; Marsal D; Denis C; Klein J; Bascands JL; Schanstra JP; Saulnier-Blache JS
    Biochem Biophys Res Commun; 2017 May; 487(1):109-115. PubMed ID: 28396151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
    Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic rewiring and epigenetic reprogramming in leptin receptor-deficient db/db diabetic nephropathy mice.
    Sarwar MS; Cheng D; Peter RM; Shannar A; Chou P; Wang L; Wu R; Sargsyan D; Goedken M; Wang Y; Su X; Hart RP; Kong AN
    Eur J Pharmacol; 2023 Aug; 953():175866. PubMed ID: 37331680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.
    Hirayama A; Nakashima E; Sugimoto M; Akiyama S; Sato W; Maruyama S; Matsuo S; Tomita M; Yuzawa Y; Soga T
    Anal Bioanal Chem; 2012 Dec; 404(10):3101-9. PubMed ID: 23052862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of kidney and protective effects of grape seed procyanidin B2 in db/db mice indicate MFG-E8 as a key molecule in the development of diabetic nephropathy.
    Zhang Z; Li BY; Li XL; Cheng M; Yu F; Lu WD; Cai Q; Wang JF; Zhou RH; Gao HQ; Shen L
    Biochim Biophys Acta; 2013 Jun; 1832(6):805-16. PubMed ID: 23474305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.